Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10359096rdf:typepubmed:Citationlld:pubmed
pubmed-article:10359096lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10359096lifeskim:mentionsumls-concept:C0031715lld:lifeskim
pubmed-article:10359096lifeskim:mentionsumls-concept:C1180347lld:lifeskim
pubmed-article:10359096lifeskim:mentionsumls-concept:C0081938lld:lifeskim
pubmed-article:10359096lifeskim:mentionsumls-concept:C0425152lld:lifeskim
pubmed-article:10359096lifeskim:mentionsumls-concept:C0033414lld:lifeskim
pubmed-article:10359096lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:10359096lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:10359096pubmed:issue5lld:pubmed
pubmed-article:10359096pubmed:dateCreated1999-6-30lld:pubmed
pubmed-article:10359096pubmed:abstractTextThe protein-tyrosine kinase Syk participates in signal transduction pathways downstream from multiple immune recognition receptors. Recent evidence indicates that Syk is also functionally coupled to cell surface integrins, which mediate interactions between the actin cytoskeleton and extracellular matrix proteins. The interactions of undifferentiated, promonocytic HL60 or U937 cells with fibronectin or anti-beta1 integrin antibodies leads to an apparent activation and tyrosine phosphorylation of Syk that is independent of tight cellular adhesion and spreading. In response to fibronectin or anti-beta1 integrin antibodies, beta1 integrins become associated with a complex of proteins that include the Lyn protein tyrosine kinase and endogenous kinase substrates of 29 and 75-80 kDa. Lyn becomes transiently activated following integrin engagement and co-localizes with the actin cytoskeleton. These studies suggest a major role for Lyn in coupling beta1 integrins to the activation of Syk.lld:pubmed
pubmed-article:10359096pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:languageenglld:pubmed
pubmed-article:10359096pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:citationSubsetIMlld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10359096pubmed:statusMEDLINElld:pubmed
pubmed-article:10359096pubmed:monthMaylld:pubmed
pubmed-article:10359096pubmed:issn0014-2980lld:pubmed
pubmed-article:10359096pubmed:authorpubmed-author:GeahlenR LRLlld:pubmed
pubmed-article:10359096pubmed:authorpubmed-author:MillerL ALAlld:pubmed
pubmed-article:10359096pubmed:authorpubmed-author:HarrisonM LMLlld:pubmed
pubmed-article:10359096pubmed:authorpubmed-author:HongJ JJJlld:pubmed
pubmed-article:10359096pubmed:authorpubmed-author:KinchM SMSlld:pubmed
pubmed-article:10359096pubmed:issnTypePrintlld:pubmed
pubmed-article:10359096pubmed:volume29lld:pubmed
pubmed-article:10359096pubmed:ownerNLMlld:pubmed
pubmed-article:10359096pubmed:authorsCompleteYlld:pubmed
pubmed-article:10359096pubmed:pagination1426-34lld:pubmed
pubmed-article:10359096pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:meshHeadingpubmed-meshheading:10359096...lld:pubmed
pubmed-article:10359096pubmed:year1999lld:pubmed
pubmed-article:10359096pubmed:articleTitleThe engagement of beta1 integrins on promonocytic cells promotes phosphorylation of Syk and formation of a protein complex containing Lyn and beta1 integrin.lld:pubmed
pubmed-article:10359096pubmed:affiliationDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette 47907, USA.lld:pubmed
pubmed-article:10359096pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10359096pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10359096pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10359096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10359096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10359096lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10359096lld:pubmed